Radiotherapy is the use of radiation, particularly X-rays for diagnosis and treatment of diseases. The other sources of radiation are gamma rays and protons. Radiotherapy is of two types namely external beam radiotherapy and internal beam radiotherapy. External radiotherapy utilizes X-rays generated from linear accelerators while internal radiotherapy is conducted by administering a radioactive material inside or close to the tumor inside the patient’s body. Radiotherapy is based on the principle of destruction of cancerous cells by damaging their DNA within these cells by radiations. Radiotherapy slows the growth of cancerous cells and is aimed at providing palliative care to relieve the patient of symptoms.
]
Radiotherapy Device Market: Drivers & Restraints

Radiotherapy is a painless treatment. Radiotherapy is widely used in cancer treatment and according to Cancer Research organization, 40% cancer cases are treated by radiotherapy. In radiotherapy, damage to surrounding healthy cells by the high dose of radiation is a side-effect which could pose a threat for market growth. The multiple side-effects of radiation therapy such as nausea, hair loss, skin problems, fatigue, appetite loss, diarrhea, fertility issues could potentially hamper radiotherapy devices market growth.

Radiotherapy Device Market: Segmentation

The global radiotherapy device market is classified on the basis of product type, end use and region.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1556

Based on product type, the global radiotherapy device market is segmented into the following:
• External Beam Radiotherapy
• Three-dimensional Conformal Radiation Therapy (3D-CRT)
• Intensity Modulated Radiation Therapy (IMRT)
• Conformal Proton Beam Radiation Therapy

Based on end use, the global radiotherapy device market is segmented into the following:
• Hospitals
• Ambulatory Surgical Centres
• Clinics

Radiotherapy Device Market: Overview

Radiation therapy controls growth or kills malignant cells by damaging their DNA through ionizing radiation. The radiation therapy devices market was valued at over US$ 4 Bn by 2015 end. In 2015, the global stereotactic radiation therapy equipment market accounted for a small share in the global radiation therapy equipment market. Cyber knife and gamma knife therapies are non-invasive and painless and integrate robotics and image guidance to locate and target lesions or tumors. Cyber knife and gamma knife are known for their radiological accuracy of 0.15 mm to 1.1 mm respectively. Unlike cyber knife, gamma knife is mainly used to treat brain tumors. Hence, the overall segment is expected to register a significant CAGR during the forecast period.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1556

Radiotherapy Device Market: Region wise Overview

Geographically, global radiotherapy device market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, Middle East and Africa (MEA).Americas & Europe regions are anticipated to lead the global radiotherapy device market with over half share in global market due to increasing geriatric population, growing demand for less time consuming treatments, increasing incidences of cancer and a shift towards painless and non-invasive surgeries. Global radiotherapy device market is largely concentrated in North America and Europe, which is estimated to account for more than 50% of the market share. Owing to a large patient population pool in China and India, radiotherapy device market is projected to grow at a significant CAGR during the forecast period.

Radiotherapy Device Market: Key Players

Key players in global radiotherapy device market are Elekta AB, Varian Medical Systems, Inc., Accuray Incorporated, GE Healthcare, Koninklijke Philips N.V., Toshiba Medical Systems Corporation, Shenzhen GeneMDx Biotech. Co., Ltd., Vision RT Ltd., IntraOp Medical, Inc., IBA, Modus Medical Devices Inc., Eckert & Ziegler, IsoRay Medical, Inc., C.R. Bard Inc., Theragenics Corporation to name a few.

Ask The Analyst@ http://www.futuremarketinsights.com/askus/rep-gb-1556